Boston Common Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Boston Common Asset Management, LLC

  • $3.84 Billion
  • Q3 2024

A detailed history of Boston Common Asset Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Boston Common Asset Management, LLC holds 29,076 shares of REGN stock, worth $20.4 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
29,076
Previous 32,372 10.18%
Holding current value
$20.4 Million
Previous $34 Million 10.16%
% of portfolio
0.8%
Previous 0.87%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024
SELL
$1024.09 - $1201.76 $3.38 Million - $3.96 Million
-3,296 Reduced 10.18%
29,076 $30.6 Million
Q2 2024

Jul 08, 2024
SELL
$883.2 - $1071.19 $1.77 Million - $2.15 Million
-2,009 Reduced 5.84%
32,372 $34 Million
Q1 2024

Apr 11, 2024
SELL
$902.69 - $993.35 $7.47 Million - $8.22 Million
-8,271 Reduced 19.39%
34,381 $33.1 Million
Q4 2023

Jan 09, 2024
SELL
$775.18 - $881.7 $1.39 Million - $1.58 Million
-1,790 Reduced 4.03%
42,652 $37.5 Million
Q3 2023

Oct 11, 2023
SELL
$692.45 - $844.37 $2.84 Million - $3.46 Million
-4,096 Reduced 8.44%
44,442 $36.6 Million
Q2 2023

Jul 24, 2023
SELL
$700.03 - $830.35 $1.88 Million - $2.23 Million
-2,689 Reduced 5.25%
48,538 $34.9 Million
Q1 2023

May 17, 2023
SELL
$680.49 - $826.97 $2.14 Million - $2.6 Million
-3,140 Reduced 5.78%
51,227 $42.1 Million
Q4 2022

Jan 26, 2023
BUY
$705.89 - $766.39 $334,591 - $363,268
474 Added 0.88%
54,367 $39.2 Million
Q3 2022

Oct 20, 2022
SELL
$573.97 - $724.32 $3.18 Million - $4.01 Million
-5,539 Reduced 9.32%
53,893 $37.1 Million
Q2 2022

Aug 10, 2022
BUY
$548.35 - $738.84 $9.16 Million - $12.3 Million
16,713 Added 39.12%
59,432 $35.1 Million
Q1 2022

May 16, 2022
BUY
$595.12 - $698.43 $385,042 - $451,884
647 Added 1.54%
42,719 $29.8 Million
Q4 2021

Jan 31, 2022
BUY
$543.48 - $670.97 $169,565 - $209,342
312 Added 0.75%
42,072 $26.6 Million
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $108,491 - $128,701
189 Added 0.45%
41,760 $25.3 Million
Q2 2021

Aug 19, 2021
BUY
$472.8 - $558.54 $7.79 Million - $9.2 Million
16,466 Added 65.59%
41,571 $23.2 Million
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $6.02 Million - $7.38 Million
13,467 Added 115.72%
25,105 $11.9 Million
Q4 2020

Feb 05, 2021
BUY
$478.3 - $607.98 $256,368 - $325,877
536 Added 4.83%
11,638 $5.62 Million
Q3 2020

Nov 10, 2020
SELL
$544.75 - $658.21 $30,506 - $36,859
-56 Reduced 0.5%
11,102 $6.22 Million
Q2 2020

Aug 10, 2020
SELL
$493.32 - $643.92 $134,676 - $175,790
-273 Reduced 2.39%
11,158 $6.96 Million
Q1 2020

May 08, 2020
SELL
$336.18 - $494.43 $1.49 Million - $2.2 Million
-4,445 Reduced 28.0%
11,431 $5.58 Million
Q4 2019

Jan 28, 2020
SELL
$274.13 - $376.51 $169,686 - $233,059
-619 Reduced 3.75%
15,876 $5.96 Million
Q3 2019

Nov 07, 2019
SELL
$273.46 - $318.39 $183,218 - $213,321
-670 Reduced 3.9%
16,495 $4.58 Million
Q2 2019

Jul 26, 2019
BUY
$299.6 - $414.82 $1.29 Million - $1.78 Million
4,298 Added 33.4%
17,165 $5.37 Million
Q1 2019

May 03, 2019
SELL
$372.08 - $439.57 $98,973 - $116,925
-266 Reduced 2.03%
12,867 $5.28 Million
Q4 2018

Jan 25, 2019
BUY
$335.82 - $403.04 $945,333 - $1.13 Million
2,815 Added 27.28%
13,133 $4.91 Million
Q3 2018

Nov 01, 2018
SELL
$351.14 - $408.51 $414,696 - $482,450
-1,181 Reduced 10.27%
10,318 $4.17 Million
Q2 2018

Aug 06, 2018
SELL
$284.6 - $344.99 $135,185 - $163,870
-475 Reduced 3.97%
11,499 $3.97 Million
Q1 2018

Apr 26, 2018
BUY
$315.82 - $393.78 $38,845 - $48,434
123 Added 1.04%
11,974 $4.12 Million
Q4 2017

Feb 07, 2018
BUY
$358.63 - $469.95 $95,395 - $125,006
266 Added 2.3%
11,851 $4.46 Million
Q3 2017

Nov 13, 2017
SELL
$431.38 - $504.0 $36,667 - $42,840
-85 Reduced 0.73%
11,585 $5.18 Million
Q2 2017

Aug 14, 2017
BUY
N/A
11,670
11,670 $5.73 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Boston Common Asset Management, LLC Portfolio

Follow Boston Common Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Common Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email